MAPK4 and neoplasm: Our current results show that MAPK4 can transform normal human mammary epithelial MCF10A cells into anchorage-independent growth in vitro but failed to transform them into tumor growth in vivo six months after initial inoculation into mammary fat pad (Fig. 4e and unpublished observation).